RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
7.80
+0.02 (0.26%)
At close: Aug 1, 2025, 4:00 PM
7.87
+0.07 (0.90%)
After-hours: Aug 1, 2025, 5:22 PM EDT
Vista Outdoor Revenue
RxSight had revenue of $37.90M in the quarter ending March 31, 2025, with 28.41% growth. This brings the company's revenue in the last twelve months to $148.31M, up 46.70% year-over-year. In the year 2024, RxSight had annual revenue of $139.93M with 57.09% growth.
Revenue (ttm)
$148.31M
Revenue Growth
+46.70%
P/S Ratio
2.09
Revenue / Employee
$297,811
Employees
498
Market Cap
316.97M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 139.93M | 50.85M | 57.09% |
Dec 31, 2023 | 89.08M | 40.07M | 81.77% |
Dec 31, 2022 | 49.01M | 26.41M | 116.90% |
Dec 31, 2021 | 22.59M | 7.92M | 53.92% |
Dec 31, 2020 | 14.68M | 12.44M | 554.98% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 57.37B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
RXST News
- 2 days ago - Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - GlobeNewsWire
- 2 days ago - RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST - PRNewsWire
- 3 days ago - RXST INVESTORS: RxSight, Inc. (NASDAQ:RXST) Investors may have been Affected by Fraud – Contact BFA Law by September 22 about Potentially Recovering Losses - GlobeNewsWire
- 5 days ago - RXST LAWSUIT: RxSight, Inc. Sued for Fraud after LDD Sales Plummet – Contact BFA Law by September 22 Court Deadline (NASDAQ:RXST) - GlobeNewsWire
- 8 days ago - Berger Montague PC Investigates Securities Claims Against RxSight, Inc. (NASDAQ: RXST) - PRNewsWire
- 10 days ago - RxSight, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 10 days ago - RXSIGHT, INC. (NASDAQ: RXST) INVESTOR ALERT Investors With Large Losses in RxSight Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 12 days ago - RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RXST - Business Wire